subscribeSubscribe
AZ`s Imfinzi fails in late-stage trial to treat certain lung cancers

AZ`s Imfinzi fails in late-stage trial to treat certain lung cancers
REUTERS
26 Jun 2024
Share Share
IMFINZI shows results in Phase III trial for muscle-invasive bladder cancer.

IMFINZI shows results in Phase III trial for muscle-invasive bladder cancer.
BUSINESSWIRE
25 Jun 2024
Share Share
AZ Imfinzi plus chemotherapy gets US nod for certain type of endometrial cancer

AZ Imfinzi plus chemotherapy gets US nod for certain type of endometrial cancer
REUTERS
17 Jun 2024
Share Share
Astrazeneca Uk Biologic Durvalumab Receives Suppl Approval in US

Astrazeneca Uk Biologic Durvalumab Receives Suppl Approval in US
FDA
14 Jun 2024
Share Share
IMFINZI Reduces Death Risk By 27% In Limited-Stage SCLC

IMFINZI Reduces Death Risk By 27% In Limited-Stage SCLC
BUSINESSWIRE
02 Jun 2024
Share Share
As Bristol Myers reveals trial failure, AstraZeneca`s Imfinzi stays king in stage 3 lung cancer

As Bristol Myers reveals trial failure, AstraZeneca`s Imfinzi stays king in stage 3 lung cancer
FIERCE PHARMA
14 May 2024
Share Share
AIM ImmunoTech: Ampligen+Imfinzi Combo Tolerated in Pancreatic Cancer Study

AIM ImmunoTech: Ampligen+Imfinzi Combo Tolerated in Pancreatic Cancer Study
GLOBENEWSWIRE
29 Apr 2024
Share Share
AstraZeneca’s earnings surprise investors as cancer drugs fuel growth

AstraZeneca’s earnings surprise investors as cancer drugs fuel growth
Jonathan Gardner BIOPHARMADIVE
26 Apr 2024
Share Share
AstraZeneca UK Imfinzi (Durvalumab) Receives Approval in the U.S.

AstraZeneca UK Imfinzi (Durvalumab) Receives Approval in the U.S.

FDA
22 Apr 2024
Share Share
IMFINZI® + Chemo Doubled 3-Yr OS In Biliary Tract Cancer TOPAZ-1

IMFINZI® + Chemo Doubled 3-Yr OS In Biliary Tract Cancer TOPAZ-1
BUSINESSWIRE
16 Apr 2024
Share Share